Dr. Zhigang Wang is a Senior Pharmacometrician at Sanofi and a voluntary researcher at KU Leuven. He previously served as a Strategic Basic Research Fellow at the Research Foundation – Flanders (FWO) and holds a PhD in Pharmacometrics from KU Leuven, where he focused on model-informed precision dosing of biologics for inflammatory bowel diseases. He also earned a Master’s degree in Pharmaceutical Modeling from Uppsala University and a Bachelor’s degree in Pharmacy from China Pharmaceutical University. Dr. Wang brings extensive experience in clinical pharmacology, pharmacometrics, model-informed precision dosing, and therapeutic drug monitoring. He is an active member of ENOTTA and contributes as a reviewer for several scientific journals and professional organizations.
Dr. Zhigang Wang is a Senior Pharmacometrician at Sanofi and a voluntary researcher at KU Leuven. He previously served as a Strategic Basic Research Fellow at the Research Foundation – Flanders (FWO) and holds a PhD in Pharmacometrics from KU Leuven, where he focused on model-informed precision dosing of biologics for inflammatory bowel diseases. He also earned a Master’s degree in Pharmaceutical Modeling from Uppsala University and a Bachelor’s degree in Pharmacy from China Pharmaceutical University. Dr. Wang brings extensive experience in clinical pharmacology, pharmacometrics, model-informed precision dosing, and therapeutic drug monitoring. He is an active member of ENOTTA and contributes as a reviewer for several scientific journals and professional organizations.